Increased expression of the homeostatic chemokines CCL19 and CCL21 in clinical and experimental Rickettsia conorii infection by Astrup, Elisabeth et al.
RESEARCH ARTICLE Open Access
Increased expression of the homeostatic
chemokines CCL19 and CCL21 in clinical and
experimental Rickettsia conorii infection
Elisabeth Astrup1,2*, Trine Ranheim2,5, Jan K Damås6,7, Giovanni Davì8, Francesca Santilli8, Mogens Jensenius4,
Giustina Vitale9, Pål Aukrust2,3,5, Juan P Olano10 and Kari Otterdal2,5
Abstract
Background: Based on their essential role in concerting immunological and inflammatory responses we
hypothesized that the homeostatic chemokines CCL19 and CCL21 may play a pathogenic role in rickettsiae
infection.
Methods: Serum levels of CCL19 and CCL21 in patients with R. africae and R. conorii infection were analyzed by
enzyme immunoassays. Lungs from R. conorii infected mice were examined for CCL19, CCL21 and CCR7 expression
by immunohistochemistry.
Results: We found that patients with R. africae infection (n = 15) and in particular those with R. conorii infection
(n = 16) had elevated serum levels of CCL19 on admission, with a decline during follow-up. While a similar pattern
was seen for CCL21 in R. africae infection, patients with R. conorii infection showed persistently increased CCL21
levels during follow-up. In experimental R. conorii infection, we found strong immunostaining of CCL19 and CCL21
in the lungs, particularly in individuals that had received lethal doses. Immunofluorescence showed co-localization
of CCR7 to endothelial cells, macrophages and fibroblasts within the lung tissue of R. conorii infected mice.
Conclusions: Our findings suggest that the CCL19/CCL21/CCR7 axis is up-regulated during R. africae and in particular
during R. conorii infection, which may potentially contribute to the pathogenesis of these disorders.
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Background
Rickettsioses are a diverse group of acute febrile in-
fections caused by obligate intracellular, vector-borne
bacteria in the family Rickettsiales. Rickettsioses can
present clinically in an array of different clinical symp-
toms; the most consistent being fever, myalgia, lymph-
adenopathy, and headache, with or without eschar and/
or maculopapular eruption [1]. The clinical spectrum of
spotted fever group (SFG) rickettsioses varies in severity
from mild (e.g., African tick bite fever [ATBF] caused by
Rickettsia africae [R. africae]) to potentially lethal dis-
ease with systemic multi-organ involvement, such as in
some cases of Mediterranean spotted fever (MSF) caused
by R. conorii [1].
SFG rickettsioses are characterized by infection of
endothelial cells and subsequent infiltration of inflam-
matory mononuclear cells that results in vasculitis and
increased microvascular permeability, which in severe
cases, could lead to cerebral and pulmonary oedema
[1,2]. The interaction between microbe and endothelial
cells during SFG rickettsioses triggers an innate immune
response. This response includes production of several
cytokines by endothelial cells and infiltrating leukocytes,
and represents both beneficial (i.e., anti-microbial) and
detrimental (e.g., excessive inflammation) responses in
relation to the host [1-3].
Based on their role in orchestrating lymphocyte traffic-
king, the chemokines CCL19 and CCL21 are commonly re-
ferred to as homeostatic chemokines. These chemokines
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are constitutively expressed in secondary lymphoid tis-
sue and regulate homing of lymphocytes and dendritic
cells through their common receptor CCR7 [4]. More
recent studies however, have suggested that CCL19 and
CCL21 may also promote inflammatory responses [5,6]
and they have been implicated in the pathogenesis of
various inflammatory disorders such as asthma, athero-
sclerosis and rheumatoid arthritis [7-9].
Based on their role in concerting immunological and in-
flammatory responses, we hypothesized that CCL19 and
CCL21 may play a pathogenic role in rickettsiae infection.
Here, we examined the expression of these chemokines in
human serum samples from patients with confirmed ATBF
and MSF. We also examined the expression of CCL19 and
CCL21 and their common receptor CCR7 in the widely ac-
cepted murine animal model for SFG rickettsioses using
C3H mice and R. conorii Malish 7 strain.
Methods
Patients and controls
The study population has previously been described
[10,11]. Briefly, the ATBF-group (n = 15, 3 women and 12
men, 20–57 [mean age 39.2 ± 12.3 years]), was recruited
from the outpatient clinic at Oslo University Hospital,
Aker between January 1999 and December 2000. All pa-
tients had characteristic signs and symptoms of active
ATBF (i.e., flu-like symptoms that manifested within the
first 10 days after they had left rural areas in South Africa
or Botswana, inoculation eschars and regional lymphaden-
itis with or without vesicular cutaneous rash, and aph-
thous stomatitis). Anti-rickettsial therapy with doxycycline
(200 mg qd for 7 days) was instituted in 12 patients. For
the study of MSF (n = 16, 7 women and 9 men, 19–74
[mean age 53.1 ± 15.6 years]), patients with confirmed
MSF, at Termini Imerese Hospital Palermo, Palermo, Italy,
between June and September 2005, were included. They
all had characteristic signs and symptoms of active MSF
(i.e., fever, eschar at the site of tick bite, and maculopapu-
lar rash). The duration of illness before diagnosis was less
than 2 weeks. All MSF patients were treated with tetracyc-
line (500 mg 4 times a day for 7 days). All MSF patients
had temperature >38.5°C and severe malaise and all were
hospitalized. In contrast, all the ATBF had a mild flu-like
illness and none needed hospitalization. Thus, although
there was no difference in disease severity within the MSF
patients (all recovered during hospitalization and none
had failure of one or more organs), these patient groups
illustrate the difference between the mild ATBF and the
more severe MSF.
Control blood samples were collected from 14 healthy
travellers (3 women and 11 men, 32–66 [mean age 44.2 ±
10.7 years]) who had returned to Norway from sub-Saharan
Africa during the preceding 7 days. Informed consent for
participation in the study was obtained from all individuals.
All parts of the study were approved by the local ethical
committee (Ethical Committee of Termini Imerese Hos-
pital Palermo, Palermo, Italy; Regional Committee for
Medical and Research Ethics, South-East Norway and Re-
gional Committee for Medical and Research Ethics, East
Norway) and conducted according to the ethical guide-
lines that are outlined in the Declaration of Helsinki.
Microbiological diagnosis
All patients with ATBF fulfilled the serological criteria
for R. africae infection: IgG plus IgM (microimmuno-
fluorescence assay) in which titers of antibodies to R.
africae were ≥2 dilutions higher than those to R. conorii;
a Western-blot profile that revealed only R. africae-
specific antibodies; or cross-adsorption studies that dem-
onstrated that the homologous antibodies were directed
against R. africae. All patients with MSF had seroconver-
sion with increases in the levels of anti-R. conorii anti-
bodies as assessed by enzyme-linked immunosorbent
assay (ELISA) and indirect immunofluorescence.
Blood sampling protocol
Peripheral venous blood was drawn into pyrogen-free,
vacuum blood collection tubes without any additives
[11] at first presentation (from days 1 to 14 after the on-
set of the symptoms and before the specific treatment)
and at follow-up (11–21 days [ATBF] and 28–42 days
[MSF] after symptom onset. Serum was stored at −80°C
until analysis and samples were thawed <4 times.
R. conorii infection in mice
R. conorii (Malish 7 strain) was obtained from the
American Type Culture Collection (ATCC VR 613). For
animal inoculation, rickettsiae were cultivated in embryo-
nated chicken eggs, followed by collection of yolk sacs
which were homogenized and diluted to obtain a 10% sus-
pension in sucrose-phosphate-glutamate (SPG) buffer
(0.218 M sucrose, 3.8 mM KH2PO4, 7.2 mM K2HPO4,
4.9 mM monosodium glutamic acid; pH 7.0). Rickettsiae
were then purified by Renografin density gradient centri-
fugation and viable rickettsiae were suspended in SPG
buffer. The concentration of rickettsiae from either a yolk
sac or cell culture was determined by a plaque assay and
quantitative real-time PCR as described below. The rick-
ettsial stock was stored at −80°C until use.
Wild-type C3H mice were purchased from Harlan La-
boratories (Indianapolis, IN) and infected between 6
to 9 weeks of age. Mice were housed in a biosafety level
3 facility at the University of Texas Medical Branch,
Galveston. All experiments and procedures were approved
by the University of Texas Medical Branch Animal Care
and Use Committee, and mice were used according to
the guidelines in the Guide for the Care and Use of La-
boratory Animals. C3H mice were infected intravenously
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through the tail vein using a lethal dose of 3 × 105 PFU
(3 LD50 doses) or a sublethal dose of 3 × 10
4 PFU (0.3
LD50 doses) of R. conorii. Negative control mice were
inoculated with 100 μl of SPG buffer alone. Mice were
monitored daily for signs of illness. Necropsies were per-
formed at 5 days post-infection and harvested organs were
fixed in 10% buffered formalin followed by paraffin
embedding.
Immunohistochemistry and immunofluorescence
Five micron sections of paraffin-embedded lungs and
spleens were deparaffinised in xylene, rehydrated in alco-
hol series and immersed in distilled water. The sections
were then treated with 0.5% H202, followed by high-
temperature antigen retrieval in citrate buffer (pH 6),
blocked with 0.5% bovine serum albumin (BSA) and in-
cubated with primary antibodies against CCR7 (ab65851,
Abcam, Cambridge, UK; 1:250), CCL19 (sc-9777, Santa
Cruz Biotechnology, Dallas, TX; 1:200) or CCL21 (AF457,
R&D Systems, Minneapolis, MN; 1:40) for 1 hour at room
temperature. After washing, the slides were incubated
for 30 minutes with peroxidase-conjugated anti-mouse
Ig (Impress-Vector, Vector Laboratories, Burlingame,
CA), rinsed, and developed with chromogen for im-
munoperoxidase staining (DAB Plus, Vector Laborato-
ries) for 7 minutes. The sections were counterstained
with hematoxylin. Omission of the primary antibody was
used as negative control.
For immunofluorescence, the slides were stained with
primary antibodies against CCR7 (NB110-55680, Novus
Biologicals, Littleton, CO; 1:200), CD31 (DIA-310, Dianova
GmbH, Hamburg, Germany; 1:50), Fibroblast Marker
(sc-73355, Santa Cruz Biotechnology, San Diego, CA;
1:100), or F4/80 (MCA497RT, AbD Serotec, Kidlington,
UK; 1:500) for 1 hour at room temperature and counter-
stained with Alexa Fluor 488 goat anti-rabbit IgG (1:500),
Alexa Fluor 568 goat anti-rat IgG (1:500) or Rat on Mouse
AP Polymer kit in combination with Warp Red Chromo-
gen kit (Biocare Medical, San Francisco, CA), respectively.
The slides were mounted with SlowFade Gold antifade
reagent with DAPI (Life Technologies, Carlsbad, CA).
Images were taken by a Nikon Eclipse E400 microscope
(Tokyo, Japan).
ELISA
Serum levels of CCL19 and CCL21 were measured by ELI-
SAs obtained from R&D Systems. The intra- and inter-
assay coefficients of variations were <10% for both ELISAs.
To further minimize run-to-run variability, serial samples
from a given individual were analyzed on the same tray.
Statistical methods
Differences between groups were compared with the
Mann–Whitney U rank-sum test for unpaired data. If
more than two groups were compared, the Kruskal-
Wallis test was used a priori. Within group differences
were analyzed with Wilcoxon rank-sum test for paired
data. The level of significance was set at p < 0.05
Results
Serum levels of CCL19 and CCL21 in ATBF and MSF patients
As seen in Figure 1A-B, patients with ATBF (n = 15) and
particularly those with MSF (n = 16) had significantly
raised serum levels of CCL19 at admission as compared
with healthy controls (n = 14). During follow-up, after
treatment with doxycycline or tetracycline in most of
the patients (see Methods), there was a significant de-
cline in CCL19 levels in both patient groups, but with-
out full normalization (Figure 1A-B). In ATBF-patients,
a similar pattern was seen for CCL21, with significantly
raised levels at admission, followed by a significant de-
cline during follow-up, without full normalization
(Figure 1C). In contrast, while MSF patients also showed
markedly persistently elevated CCL21 levels at admis-
sion, there was no significant changes during follow-up
with a non-significant rise (p = 0.07) rather than a de-
cline in CCL21 levels (Figure 1D).
All ATBF had a mild flu-like illness and none needed
hospitalization, representing a mild form of SFG rickett-
sioses, whereas all MSF patients had temperature
>38.5°C and severe malaise and all were hospitalized,
representing a more severe form of SFG rickettsioses. At
baseline CCL19, but not CCL21, tended to be higher in
patients with MSF although the difference did not reach
statistical significance (p = 0.08). At follow-up, there
were no differences in CCL19 and CCL21 levels between
ATBF and MSF patients. However, when comparing
changes from baseline to follow-up, the difference be-
tween the two patient groups were statistical significant
for CCL21 (p < 0.01), but not for CCL19, reflecting per-
sistently raised CCL21 levels in patients with the more
severe MSF compared to a decline during follow-up in
patients with ATBF.
CCL19, CCL21 and CCR7 expression in experimental R.
conorii infection
To further study the regulation of the homeostatic che-
mokines CCL19 and CCL21 in SFG rickettsial infection,
we examined the expression of these chemokines and
their common receptor CCR7 in lungs from mice in-
fected with sub-lethal and lethal doses of R. conorii as
well as in uninfected mice. While only weak immuno-
staining of CCL19, CCL21 and CCR7 was seen in unin-
fected mice, strong staining was seen in R. conorii
infected mice with particularly strong immunostaining
in those that had received lethal doses (Figure 2). In gen-
eral, a similar pattern was seen for CCL19, CCL21 and
CCR7, but with a more prominent immunostaining for
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CCL21 than for CCL19. CCL19 and CCL21 interact with
their common receptor CCR7, and immunofluorescence
showed co-localization of CCR7 to endothelial cells,
macrophages and fibroblasts within the infected lung tis-
sue (Figure 3).
We also examined the expression of CCL19, CCL21 and
CCR7 by immunohistochemistry in secondary lymphoid
organ (i.e., spleen) during experimental R. conorii infection
(Figure 4). As expected, the immunostaining of these
markers was in general stronger in the spleen as compared
with the lungs. Moreover, although the staining for
CCL19 and in particular CCL21 was stronger in the R.
conorii infected mice (lethal dose) as compared with the
non-infected mice, this was not seen for CCR7, and the
differences were less prominent than in the lungs. Unfor-
tunately, we lack sections from spleen in mice infected
with sub-lethal doses of R. conorii. Whereas these findings
may suggest enhanced CCL19/CCL21 expression within
the spleen in R. conorii infected mice, the regulation of
CCL19/CCL21/CCR7 seems in general to be less influ-
enced by R. conorii infection in this secondary lymphoid
organ than in the lungs.
Discussion
Inflammatory chemokines such as the T-cell targeting
chemokines CXCL10 and CXCL19 and the endothelial
related chemokine CX3CL1 have previously been linked
to the immune response against SFG rickettsial infection
[12-15]. In the present study, we show that increased ex-
pression of chemokines during SFG rickettsial infection
is not restricted to the inflammatory chemokines, but
seems also to involve the homeostatic chemokines
CCL19 and CCL21. Thus, we show increased expression
of these chemokines in clinical (ATBF and MSF) and ex-
perimental (R. conorii) rickettsial infection. There are in-
creased levels both systemically (ATBF and MSF), in the
spleen, and in particular, in the lungs (experimental R.
conorii infection). Within the lungs, strong immuno-
staining of CCR7 was seen co-localized to endothelial
cells, macrophages and fibroblasts during lethal experi-
mental R. conorii infection in mice.
Enhanced levels of the homeostatic chemokines CCL19
and CCL21 have previously been related to viral replica-
tion [16] and disease severity [17] in HIV infection and
cytomegalovirus-induced disease in solid organ transplant
Figure 1 Levels of CCL19 and CCL21 in patients and controls. Serum levels of CCL19 (A and B) and CCL21 (C and D) is shown for 15
patients with African tick bite fever (ATBF, R. africae) ,16 patients with Mediterranean spotted fever (MSF, R. conorii) and for 14 healthy controls.
Blood samples from patients were collected at admission (baseline, basel.) and follow-up (FU), 11–21 days [ATBF] and 28–42 days [MSF] after
symptom onset. Twelve of the ATBF were treated with doxycycline for 7 days and all MSF patients were treated with tetracycline for 7 days
following admission. Data are given as medians, 25-75 the percentiles and ranges. *p < 0.01 and ***p < 0.001 versus controls. ##p < 0.01 and
###p < 0.001 versus admission.
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recipients (CCL21) [18]. High levels have also been associ-
ated with mycobacterial infections [17,19]. In the present
study, we, to the best of our knowledge, for the first time
show that rickettsial infection is characterized by increased
levels of CCL19 and CCL21 as well as their common recep-
tor CCR7 being prototypical homeostatic chemokines/che-
mokine receptor. Moreover, in experimental murine R.
conorii infection increased expression of CCL19 and CCR7
and in particular, CCL21 was associated with lethal infec-
tion. Also, while CCL21 declined during follow-up in ATBF,
representing a mild form of SFG rickettsioses, persistently
high CCL21 levels were seen in patients with the more se-
vere MSF. In contrast to CCL21, CCL19 decreased during
follow-up in both ATBF and MSF. This could be related to
the fact that CCL19 and CCL21, at least to some degree,
have different cellular sources. While CCL19 is produced
by a wide range of cells such as circulating T cells and
monocytes, the production of CCL21 seems to be restricted
to stromal cells and tissue macrophages. It is therefore pos-
sible that serum levels of CCL21 in MSF patients more dir-
ectly reflect the levels within the inflamed and infected
tissue such as the lungs.
The pathogenic consequences of the increased expression
of CCL19, CCL21 and CCR7 during R. conorii infection are
not clear at present. Although CCR7 deficient mice were
found to have compromised resistance when infected with
high doses of Mycobacterium tuberculosis [20], high levels
of CCR7 and its ligands may not necessarily be beneficial.
In fact, respiratory syncytial virus infection may accelerate
pulmonary disease via CCR7-related mechanisms [21].
Moreover, CCL19 and CCL21 have been found to pro-
mote an inflammatory response in peripheral blood
mononuclear cells from HIV infected patients when
accompanied by high viral load, a process that could be
related to the inappropriate immune activation and in-
flammation that is seen in these patients [22]. Although it
is tempting to hypothesize that the enhanced expression
of CCL19 and CCL21 during R. conorii infection could
contribute to tissue necrosis and overwhelming inflamma-
tory responses, these issues need to be investigated in
more mechanistic studies. Interestingly, Choi et al. have
recently shown that Orientia tsutsugamushi impairs the
CCL19 mediated effects on dendritic cell migration [23],
and it will be of importance to examine if similar mecha-
nisms could be seen during R. conorii infection.
The present study has some limitations such as the in-
clusion of a relatively low number of patients, and we
have no data on the expression of these chemokines in
relation to the degree of disease severity within the
spectrum of MSF-related disease. Moreover, recent studies
suggest that an MSF-like syndrome is not restricted to R.
conorii infection, but can also be seen during infection
Control Sublethal Lethal
CCL19
CCL21
CCR7
100 μm
Figure 2 Immunohistochemical staining of CCR7, CCL19 and CCL21 in lung tissue. Staining of CCR7, CCL19 and CCL21 in lung tissue from
control mice and from mice with sublethal and lethal doses of R. conorii infection is shown. Left panels show staining of lungs from controls.
Middle panels and right panels show lungs from mice with sub-lethal and lethal infections, respectively. The panels show representative images
from three mice in each group obtained with 10x objective. Scale bar: 100 μm.
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Figure 3 (See legend on next page.)
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with R. massiliae, R. sibirica mongolitimonae, R. mona-
censi [24], and the exclusion of these different species is
very difficult by serological tests that were used in the
present study. Also, the lack of data on the effects of
CCL19 and CCL21 on rickettsia related immunity and
inflammation as well as the lack of studies on experi-
mental R. conorii infection in CCR7 deficient mice make
it hard to draw any mechanistic conclusion from our
data. However, our findings suggest that the CCL19/
CCL21/CCR7 axis is up-regulated during R. africae and
in particular during R. conorii infection, and future
studies should examine the pathogenic consequences of
these findings.
Conclusions
In this study, we observe an increase in serum levels of
the so-called homeostatic chemokines CCL19 and CCL21
in the acute phase of ATBF and MSF. The effect is
more pronounced in MSF, which is also normally the
more clinically severe rickettsiosis of the two, and only
in ATBF did both chemokines approach levels similar
to controls in the reconvalescence phase. Parallel to
this, immunohistochemistry examination of lung tissue
from experimental R. conorii infection in mice showed
increased expression of both CCL19 and CCL21 as
well as their common receptor CCR7, co-localized to
endothelial cells, macrophages and fibroblasts, with a
(See figure on previous page.)
Figure 3 Immunofluorescence staining of CCR7 in lung tissue. Staining shows co-localization of CCR7 with endothelial cells, fibroblasts and
macrophages in murine lungs infected with R. conorii (lethal infection). Lung sections were stained with CCR7 in combination with endothelial,
fibroblast and macrophage cell markers. CCR7 was counterstained with Alexa Fluor 488 conjugated goat anti-rabbit IgG (green). Endothelial and
fibroblast cell markers were counterstained with Alexa Fluor 568 conjugated goat anti-rat IgG (red). Macrophages were counterstained with
Warp red chromogen. The nuclei were stained with Dapi (blue). Overlays are shown in the left panels. For a better visualization of
co-localization of CCR7 with cell markers, inserts are overlays of only green and red staining. Similar results were obtained in 3 separate
experiments.
Control Lethal
CCL19
CCL21
CCR7
20 μm
Figure 4 Immunohistochemical staining of CCR7, CCL19 and CCL21 in spleen. Panels show immunostaining of spleen from mice subjected
to R. conorii infection. Left panels show staining of spleen from controls. Right panels show spleen from mice infected with lethal doses of R.
conorii. Representative images from three mice in each group obtained with 40X objective. Scale bar: 20 μm.
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more profound effect in those infected with lethal dose
of R. conorii. If these findings reflect that CCL19 and
CCL21 not only carry out their homeostatic role, but
also play a pathogenic role in these infections, this
should be examined in forthcoming studies.
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